Lactulose
CHEBI:CHEBI_6359
Definition
A synthetic galactosylfructose disaccharide used in the treatment of constipation and hepatic encephalopathy.
Chemical Information
- Molecular Formula
- C12H22O11
- Molecular Mass
- 342.29650
- Charge
- 0
- SMILES
- OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O
- InChI
- InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12-/m1/s1
- InChIKey
- JCQLYHFGKNRPGE-FCVZTGTOSA-N
Alternative Names
- 4-O-beta-D-galactopyranosyl-beta-D-fructofuranose
- 4-O-beta-D-Galactopyranosyl-D-fructofuranose
- 4-O-beta-D-Galactopyranosyl-D-fructose
- D-Lactulose
- lactulosa
- lactulose
- Lactulose
- lactulosum
Treatment Applications
-
microlissencephalyView Disease →
DOID:0112234
-
lactose intoleranceView Disease →
DOID:10604
-
acute necrotizing encephalitisView Disease →
DOID:5222
Drug Classification
-
glycosylfructoseView Class →
CHEBI:35378
-
t262708
-
t262764
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Wikipedia:Lactulose
- DRON_00010000
- 6218
- core#notation
- CHEBI:6359
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- package_description
- 5 TRAY in 1 CASE (66689-039-50) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (66689-039-01)
- package_ndc
- 61037-471-12
- rxcui
- 1251196
- manufacturer_name
- Foxland Pharmaceuticals, Inc.
- package_marketing_start_date
- 24-APR-91
- nui
- N0000175833
- active_ingredient_name
- LACTULOSE
- active_ingredient_strength
- 1250 kg/1250kg
- unii
- 9U7D5QH5AE
- spl_set_id
- 4089ccd2-e58d-4d2b-a9f0-40fcd9aaf615
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Lactulose
- DRON_00010000
- 6218
- oboInOwl#hasAlternativeId
- CHEBI:302765
- oboInOwl#id
- CHEBI:6359
- generic_name
- LACTULOSE
- brand_name
- KRISTALOSE
- brand_name_base
- KRISTALOSE
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- POWDER, FOR SOLUTION
- product_ndc
- 66689-039
- application_number
- ANDA074138
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_55324
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- listing_expiration_date
- 20241231
- route
- RECTAL
- labeler_name
- Danipharm A/S
- marketing_start_date
- 19910424
- spl_id
- bf46fee5-e970-4f20-b389-958e5d55c28e
- core#notation
- CHEBI:6359
- pharm_class_moa
- Acidifying Activity [MoA]
- pharm_class
- Acidifying Activity [MoA]
- pharm_class_epc
- Osmotic Laxative [EPC]
- pharm_class_pe
- Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- upc
- 0366220719017
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_13413
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111400
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30495
- owl#annotatedSource
- t262914
- owl#someValuesFrom
- t3103708